| Product Code: ETC11387503 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antibody Discovery Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antibody Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antibody Discovery Market - Industry Life Cycle |
3.4 Israel Antibody Discovery Market - Porter's Five Forces |
3.5 Israel Antibody Discovery Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Israel Antibody Discovery Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.7 Israel Antibody Discovery Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
4 Israel Antibody Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development of therapeutic antibodies in Israel |
4.2.2 Growing prevalence of chronic diseases driving the demand for innovative antibody therapies |
4.2.3 Technological advancements in antibody discovery methods and tools in the Israeli market |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for antibody development and commercialization in Israel |
4.3.2 Limited availability of skilled professionals specialized in antibody discovery and development in the country |
5 Israel Antibody Discovery Market Trends |
6 Israel Antibody Discovery Market, By Types |
6.1 Israel Antibody Discovery Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Israel Antibody Discovery Market Revenues & Volume, By Technology, 2021 - 2031F |
6.1.3 Israel Antibody Discovery Market Revenues & Volume, By Hybridoma, 2021 - 2031F |
6.1.4 Israel Antibody Discovery Market Revenues & Volume, By Phage Display, 2021 - 2031F |
6.1.5 Israel Antibody Discovery Market Revenues & Volume, By Single-Cell Screening, 2021 - 2031F |
6.2 Israel Antibody Discovery Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Israel Antibody Discovery Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.2.3 Israel Antibody Discovery Market Revenues & Volume, By Academic Institutes, 2021 - 2031F |
6.2.4 Israel Antibody Discovery Market Revenues & Volume, By CROs, 2021 - 2031F |
6.3 Israel Antibody Discovery Market, By Therapeutic Area |
6.3.1 Overview and Analysis |
6.3.2 Israel Antibody Discovery Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.3 Israel Antibody Discovery Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.3.4 Israel Antibody Discovery Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
7 Israel Antibody Discovery Market Import-Export Trade Statistics |
7.1 Israel Antibody Discovery Market Export to Major Countries |
7.2 Israel Antibody Discovery Market Imports from Major Countries |
8 Israel Antibody Discovery Market Key Performance Indicators |
8.1 Number of research grants allocated to antibody discovery projects in Israel |
8.2 Number of patents filed for novel antibody technologies in Israel |
8.3 Percentage increase in collaboration agreements between Israeli biotech companies and global pharmaceutical firms in the field of antibody discovery. |
9 Israel Antibody Discovery Market - Opportunity Assessment |
9.1 Israel Antibody Discovery Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Israel Antibody Discovery Market Opportunity Assessment, By End User, 2021 & 2031F |
9.3 Israel Antibody Discovery Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10 Israel Antibody Discovery Market - Competitive Landscape |
10.1 Israel Antibody Discovery Market Revenue Share, By Companies, 2024 |
10.2 Israel Antibody Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here